Lifebit has announced a partnership with Troper Wojcicki Philanthropies (TWP), which deploys philanthropy and mission-related investments in key priority areas including accelerating cancer research.
Clinigen, the global speciality pharmaceutical services group, and Essential Pharma, an international specialty pharmaceutical group, has announced an expansion of their JAPAC collaboration.
Clinigen has announced a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen has acquired a minority stake in Tepsivo.
Cancer Research Horizons has joined Lifebit’s Federated Data Network to help maximise the impact of data generated through Cancer Research UK-funded research.
Absci Corporation and Owkin have announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients.
Pioneer Group has announced a collaboration agreement with Thermo Fisher Scientific to support biotech founders on their journey towards commercialising intellectual property in the healthcare and sustainability sectors.
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program.
Asahi Kasei Pharma has taken another step in its transformation into a global specialty pharmaceuticals company through a new licensing agreement with Chiome Bioscience for its humanised anti-CX3CR1 antibody.
Medilink North of England has signed a Memorandum of Understanding (MoU) with Bochum Health Agency, part of Bochum Economic Development in Germany, for increased trade and partnerships between the two regions.
UK-based Concept Life Sciences (Concept) and Accelero Biostructures (Accelero) in the US have formed a partnership which will help pharma businesses worldwide speed up drug development by up to tenfold.
Brenntag has announced a new strategic partnership with K+S Minerals and Agriculture – a globally oriented raw materials company – for the worldwide distribution of three pharmaceutical salts.
